Effectiveness of topical hyaluronic acid of different molecular weights in xerosis cutis treatment in elderly: a double-blind, randomized controlled trial
- PMID: 38829483
- DOI: 10.1007/s00403-024-03003-2
Effectiveness of topical hyaluronic acid of different molecular weights in xerosis cutis treatment in elderly: a double-blind, randomized controlled trial
Abstract
Dry skin is a common dermatological condition that frequently affects the elderly. A contributing cause to dry skin is a reduced concentration of hyaluronic acid (HA) in both the epidermis and dermis. The effectiveness of moisturizer containing HA as a therapy for dry skin is impacted by its specific molecular weight. Low molecular weight HA (LMWHA) is believed to be more effective in replenishing skin hydration in aging skin compared to High Molecular Weight HA (HMWHA) due to its ability to penetrate the stratum corneum. However, there is a lack of clinical research supporting this claim. A double-blind, randomized controlled trial was conducted on 36 residents of a nursing home in Jakarta. The participants, aged between 60 and 80 years, had been diagnosed with dry skin. Each test subject was administered three distinct, randomized moisturizing lotions (LMWHA, HMWHA, or vehicle), to be topically applied to three separate sites on the leg. Skin capacitance (SCap), transepidermal water loss (TEWL), and specified symptom sum score (SRRC) were measured at weeks 0, 2, and 4. After four weeks of therapy, area that was treated with LMWHA showed greater SCap values compared to the area treated with HMWHA (56.37 AU vs. 52.37 AU, p = 0.004) and vehicle (56.37 AU vs. 49.01 AU, p < 0.001). All groups did not show any significant differences in TEWL and SRRC scores. No side effects were found in all groups. The application of a moisturizer containing LMWHA to the dry skin of elderly resulted in significant improvements in skin hydration compared to moisturizers containing HMWHA and vehicle. Furthermore, these moisturizers demonstrated similar safety in treating dry skin in the elderly. ClinicalTrials.gov Identifier NCT06178367, https://clinicaltrials.gov/study/NCT06178367 .
Keywords: Dry skin; Elderly; High molecular weight hyaluronic acid; Low molecular weight hyaluronic acid; Moisturizer; Topical.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Efficacy of anti-inflammatory moisturizer vs hydrophilic cream in elderly patients with moderate to severe xerosis: A split site, triple-blinded, randomized, controlled trial.J Cosmet Dermatol. 2020 Jun;19(6):1432-1438. doi: 10.1111/jocd.13183. Epub 2019 Oct 14. J Cosmet Dermatol. 2020. PMID: 31609077 Clinical Trial.
-
The 24-hr, 28-day, and 7-day post-moisturizing efficacy of ceramides 1, 3, 6-II containing moisturizing cream compared with hydrophilic cream on skin dryness and barrier disruption in senile xerosis treatment.Dermatol Ther. 2019 Nov;32(6):e13090. doi: 10.1111/dth.13090. Epub 2019 Oct 9. Dermatol Ther. 2019. PMID: 31585489 Clinical Trial.
-
Pilot Comparative Study of the Topical Action of a Novel, Crosslinked Resilient Hyaluronic Acid on Skin Hydration and Barrier Function in a Dynamic, Three-Dimensional Human Explant Model.J Drugs Dermatol. 2016 Apr;15(4):434-41. J Drugs Dermatol. 2016. PMID: 27050698
-
Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders.Am J Clin Dermatol. 2003;4(11):771-88. doi: 10.2165/00128071-200304110-00005. Am J Clin Dermatol. 2003. PMID: 14572299 Review.
-
Restoring Skin Hydration and Barrier Function: Mechanistic Insights Into Basic Emollients for Xerosis Cutis.Int J Dermatol. 2025 Jun;64 Suppl 1:5-12. doi: 10.1111/ijd.17790. Epub 2025 Apr 15. Int J Dermatol. 2025. PMID: 40231699 Review.
Cited by
-
Assessment of the Curative Anti-Glycation Properties of a Novel Injectable Formulation Combining Dual-Weight Hyaluronic Acid (Low- and Mid/High-Molecular Weight) with Trehalose on Human Skin Ex Vivo.Int J Mol Sci. 2025 May 15;26(10):4747. doi: 10.3390/ijms26104747. Int J Mol Sci. 2025. PMID: 40429894 Free PMC article.
References
-
- Legiawati L, Yusharyahya SN, Sularsito SA, Setyorini ND (2017) Insidens penyakit kulit di Divisi Dermatologi Geriatri Poliklinik Kulit Dan Kelamin Rumah Sakit Dr. Cipto Mangunkusumo Tahun 2008–2013. MDVI 44(1):20–26
-
- Augustin M, Wilsmann-Theis D, Körber A, Kerscher M, Itschert G, Dippel M et al (2019) Diagnosis and treatment of xerosis cutis – a position paper. JDDG - J Ger Soc Dermatology 17(S7):3–33
-
- Bravo B, Correia P, Gonçalves Junior JE, Sant’Anna B, Kerob D (2022) Benefits of topical hyaluronic acid for skin quality and signs of skin aging: from literature review to clinical evidence. Dermatol Ther. ;1–9
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical